Schizophrenia Research
Volume 93, Issue 1 , Pages 33-41 , July 2007

DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia

Received 30 August 2006 ,Revised 23 January 2007 ,Accepted 26 January 2007.

References 

  1. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol. 1993;170:1–8
  2. Baker SC, Frith CD, Dolan RJ. The interaction between mood and cognitive function studied with PET. Psychol. Med. 1997;27:565–578
  3. Benes FM. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 2000;31:251–269
  4. Benes FM, Beretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 2001;25:1–27
  5. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry. 1991;48:996–1001
  6. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 1992;12:924–929
  7. Benes FM, Walsh J, Bhattacharyya S, Sheth A, Berretta S. DNA fragmentation decreased in schizophrenia but not bipolar disorder. Arch. Gen. Psychiatry. 2003;60:359–364
  8. Benes FM, Matzilevich D, Burke RE, Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol. Psychiatry. 2006;11:241–251
  9. Bouras C, Kovari E, Hof PR, Riederer BM, Giannakopoulos P. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol. (Berl). 2001;102:373–379
  10. Chuang DM, Chen RW, Chalecka-Franaszek E, Ren M, Hashimoto R, Senatorov V, et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 2002;4:129–136
  11. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry. 2001;58:545–553
  12. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262:689–695
  13. Davenport CJ, Brown WJ, Babb TL. GABAergic neurons are spared after intrahippocampal kainate in the rat. Epilepsy Res. 1990;5:28–42
  14. Davidson M, Harvey P, Welsh KA, Powchik P, Putnam KM, Mohs RC. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. Am. J. Psychiatry. 1996;153:1274–1279
  15. Debatin KM, Poncet D, Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene. 2002;21:8786–8803
  16. Didier M, Bursztajn S, Adamec E, Passani L, Nixon RA, Coyle JT, et al. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J. Neurosci. 1996;16:2238–2250
  17. Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–827
  18. Eastwood SL, Harrison PJ. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res. Bull. 2001;55:569–578
  19. Erkwoh R, Sabri O, Steinmeyer EM, Bull U, Sass H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatr. Scand. 1997;96:51–57
  20. Evan G, Littlewood T. A matter of life and cell death. Science. 1998;281:1317–1322
  21. Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel BV, Lohr J, et al. Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am. J. Psychiatry. 1997;154:682–684
  22. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry. 2002;59:521–529
  23. Jarskog LF, Gilmore JH, Selinger ES, Lieberman JA. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol. Psychiatry. 2000;48:641–650
  24. Jin K, Chen J, Nagayama T, Chen M, Sinclair J, Graham SH, et al. In situ detection of neuronal DNA strand breaks using the Klenow fragment of DNA polymerase I reveals different mechanisms of neuron death after global cerebral ischemia. J. Neurochem. 1999;72:1204–1214
  25. Knable MB. Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection. Schizophr. Res. 1999;39:149–152(discussion 163)
  26. Lenox RH, Wang L. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks. Mol. Psychiatry. 2003;8:135–144
  27. Li X, Bijur GN, Jope RS. Glycogen synthase kinase-3-beta, mood stabilizers, and neuroprotection. Bipolar Disord. 2002;4:137–144
  28. Lopez-Larson MP, DelBello MP, Zimmerman ME, Schwiers ML, Strakowski SM. Regional prefrontal gray and white matter abnormalities in dipolar disorder. Biol. Psychiatry. 2002;52:93–100
  29. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol. Bull. 2001;35:5–49
  30. Manji HK, Moore GJ, Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J. Clin. Psychiatry. 2000;61(Suppl 9):82–96
  31. Morin F, Beaulieu C, Lacaille JC. Selective loss of GABA neurons in area CA1 of the rat hippocampus after intraventricular kainate. Epilepsy Res. 1998;32:363–369
  32. Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)—Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J. Neuropathol. Exp. Neurol. 1999;58:1147–1155
  33. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U. S. A. 1998;95:13290–13295
  34. Rubinsztein JS, Fletcher PC, Rogers RD, Ho LW, Aigbirhio FI, Paykel ES, et al. Decision-making in mania: a PET study. Brain. 2001;124:2550–2563
  35. Stone DJ, Walsh J, Benes FM. Localization of cells preferentially expressing GAD(67) with negligible GAD(65) transcripts in the rat hippocampus. A double in situ hybridization study. Brain Res. Mol. Brain Res. 1999;71:201–209
  36. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 2001;55:597–610
  37. Wang JF, Azzam JE, Young LT. Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience. 2003;116:485–489

PII: S0920-9964(07)00072-2

doi: 10.1016/j.schres.2007.01.030

Schizophrenia Research
Volume 93, Issue 1 , Pages 33-41 , July 2007

Article Tools

* Image Usage & Resolution